Research Article
The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
Table 1
Clinical and pathological characteristics.
| Characteristics | Number | Percent (%) |
| Total patients | 96 | 100.0 | Gender | | | Male | 78 | 81.3 | Female | 18 | 18.7 | Years ≥ 65 | | | Yes | 26 | 27.1 | No | 70 | 72.9 | Targeted therapy | | | Sunitinib | 35 | 36.5 | Sorafenib | 37 | 38.5 | No | 24 | 25.0 | Pathology | | | Clear cell | 90 | 93.8 | Papillary | 5 | 5.2 | Undifferentiated | 1 | 1.0 | Sarcomatoid dedifferentiation | | | Yes | 11 | 11.5 | No | 85 | 88.5 | T | | | T1-2 | 55 | 57.3 | T3-4 | 41 | 42.7 | N | | | N0 | 87 | 90.6 | N1-2 | 9 | 9.4 | G | | | G1-2 | 68 | 70.8 | G3-4 | 28 | 29.2 |
| Metastatic sites | | | Lung | 55 | 57.3 | Bone | 39 | 40.6 | Liver | 8 | 8.3 | Brain | 4 | 4.2 | Adrenal gland | 14 | 14.6 | Retroperitoneal lymph node | 13 | 13.5 | Supradiaphragmatic lymph node | 4 | 4.2 | Others | 7 | 7.3 | Metastatic organ | | | 1 | 61 | 63.5 | ≥2 | 35 | 36.5 | Disease-free interval | | | ≤12 months | 53 | 55.2 | >12 months | 43 | 44.8 | Metastasectomy | | | Complete resection | 31 | 32.3 | Incomplete resection | 11 | 11.5 | No resection | 54 | 56.3 |
|
|